Search

Search Constraints

You searched for: Author/Creator Goodsaid, Federico

Search Results

1. A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2‐73) Phase 2a clinical study. Issue 1 (19th April 2020)

4. DT‐01‐05: SYSTEMATIC PROCESSING OF FULL GENOMIC ANALYSIS OF THE ANAVEX®2‐73 PHASE 2A ALZHEIMER'S DISEASE STUDY IDENTIFIES BIOMARKERS ENABLING A PRECISION MEDICINE APPROACH. (1st July 2006)

6. P4‐206: FULL GENOMIC ANALYSIS OF ANAVEX®2‐73 PHASE 2A ALZHEIMER'S DISEASE STUDY IDENTIFIES BIOMARKERS ENABLING TARGETED THERAPY AND A PRECISION MEDICINE APPROACH. (1st July 2006)

9. The current status of biomarkers for predicting toxicity. (November 2013)